Previous 10 | Next 10 |
CHATHAM, N.J., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase 1,400,000 shares of Seri...
CHATHAM, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present at the ThinkEquity Conference on Wednesday, Oc...
NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street , a nationally syndicated TV show, announces episode #397 airing on the Fox Business Network, tonight, Monday, October 17, 2022, at 10:30 PM PT. 1). The Sustainable Green Team...
CHATHAM, N.J., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will participate in one-on-one meetings at the 2022 BI...
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New To The Street / Newsmax announces its 396th show lineup, which features the following nine (9) Corporate interviews, airing Sunday, October 16, 2022, 10-11 AM ET: 1). The Sustainable Team’s (...
NEW YORK, Oct. 13, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street announces the broadcasting of its business show broadcasting as a sponsored program on Bloomberg TV , October 13, 2022, at 9:30 PM PT. New to The Street’s TV show will air the follo...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from A...
The U.S. Food and Drug Administration (FDA) cleared Tonix Pharmaceuticals' ( NASDAQ: TNXP ) application seeking to start a phase 2 of TNX-601 ER to treat major depressive disorder (MDD). TNX-601 ER (tianeptine hemioxalate extended-release tablets) is a once-daily formu...
TNX-601 ER, Tianeptine Hemioxalate, is an Extended-Release Tablet for Once-a-Day Dosing Phase 2 Clinical Trial of TNX-601 ER Expected to Start First Quarter 2023 CHATHAM, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Toni...
NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New To The Street / Newsmax TV announces its Corporate interviews on the 389th show, airing Sunday, September 25, 2022, 10-11 AM ET: 1). PetVivo Holdings, Inc.’s (NASDAQ: PETV) (NASDAQ: PETVW)...
News, Short Squeeze, Breakout and More Instantly...
Tonix Pharmaceuticals Holding Corp. Company Name:
TNXP Stock Symbol:
NASDAQ Market:
Tonix Pharmaceuticals Holding Corp. Website:
3 Tips for Conducting Research With Penny Stocks Penny stocks are investments that require investors to conduct more due diligence prior to entering than with blue chips. Before investing in penny stocks , it’s important to understand the risks associated with penny stocks and do y...